Organization
Cepheid
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Cepheid
... D.C.-based Danaher came in fourth, driven by acquisitions of Beckman Coulter and Cepheid in recent years. The determination was made based on estimated 2017 revenues ...
... are Roche, Hologic, Becton Dickinson, Myraid Genetics, Qiagen, Abbott, Siemens, bioMérieux and Cepheid. Renub Research study titled "United States Molecular Diagnostics Market, Test Volume Forecast ...
... Bio-Rad Laboratories Hemoglobinopathy and Diabetes Testing Blood Typing and Testing Tissue Typing Cepheid Molecular Hospital-Acquired Infection (HAI) Testing Molecular Sexual Health and Women's Health Testing ...
... key players including Thermo Fisher Scientific Inc.; Bio-Rad Laboratories; QIAGEN; Abbott; and Cepheid dominated the global qPCR and dPCR market in 2016. Companies Mentioned Affymetrix, ...
... Cepheid announced today that it has received clearance from the U.S. Food and ...
... are Roche, Hologic, Becton Dickinson, Myraid Genetics, Qiagen, Abbott, Siemens, bioMrieux and Cepheid. This 146 page report with 87 Figures and 4 Tables studies the ...
... are Roche, Hologic, Becton Dickinson, Myraid Genetics, Qiagen, Abbott, Siemens, bioMrieux and Cepheid. Key Players in the United State Molecular Diagnostics Market According to this ...
... Biocartis and Microbiome Collaborated to Develop Rapid and Sensitive Sepsis Test Solution Cepheid Obtains FDAs Emergency Use Authorization for Xpert Ebola Diagnostic Test ARKRAY unveils ...
... to customers through Danaher Corporation's network of companies, which include Beckman Coulter, Cepheid, Leica Biosystems, Radiometer and SCIEX Diagnostics. The breadth of offerings extends from ...
... a developer of innovative molecular diagnostic solutions, today announced an agreement with Cepheid for distribution of its PlexPCR(TM) and ResistancePlus(TM) molecular diagnostic products in key ...
... POC Market - Trend - Retail Clinics - Trend - Danaher Buys Cepheid - Trend - "Star Trek" POC Devices - Trend - Alere and ...
... market. It also provides market data, including: - Alere - Abbott, Danaher Cepheid and Other Industry Developments - Size and Growth of the Point-of-Care Diagnostics ...
... Diagnostic market are Abbott, Affymetrix, Beckman Coulter Inc, Becton Dickinson, BioMerieux, Bio-Rad, Cepheid, Diamedix, Elitech Group, Qiagen, Siemens, Thermo Fisher Scientific, GlaxoSmithCline and Merck & ...
... contributing significantly to the next generation cancer diagnostics market are Novartis AG; Cepheid; Hoffman La Roche Ltd.; PerkinElmer, Inc.; Sysmex Corporation; Abbott; Thermo Fisher Scientific, ...
... by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, ...
... (iNAT), which amplifies viral DNA faster than polymerase chain reaction (PCR). Meanwhile, Cepheid received FDA clearance last month to market its own newer, faster molecular ...
... 2025, with bioMrieux, Becton, Dickinson and Company, Thermo Fisher Scientific, Roche Diagnostics, Cepheid & Beckman Coulter Dominating - Research and Markets ...
... �Cepheid today announced that it has received clearance from the U.S. Food and ...
... Molecular diagnostics company Cepheid made the highest amount of non-research payments out of the more than ...
... and James N. Ingle from Mayo Clinic. Under a license agreement between Cepheid and the Johns Hopkins University, Sukumar and Wolff are entitled to future ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤